Search Results - "Potter, Mike N"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    The impact of extramedullary disease at presentation on the outcome of myeloma by Wu, Ping, Davies, Faith E., Boyd, Kevin, Thomas, Karen, Dines, Sharon, Saso, Radovan M., Potter, Mike N., Ethell, Mark E., Shaw, Bronwen E., Morgan, Gareth J.

    Published in Leukemia & lymphoma (01-01-2009)
    “…This study was conducted to compare the presenting features and outcome of newly-diagnosed myeloma with and without extramedullary (EM) manifestations and to…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The feasibility of plerixafor as a second-line stem cell mobilizing agent in children by Aabideen, Kanakkande, Anoop, Parameswaran, Ethell, Mark E, Potter, Mike N

    Published in Journal of pediatric hematology/oncology (01-01-2011)
    “…In patients heavily pretreated with myelosuppressive chemotherapy or irradiation, Granulocyte colony stimulating factor (G-CSF) may fail to mobilize stem cells…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations by Scott, Richard H, Homfray, Tessa, Huxter, Nicola L, Mitton, Sally G, Nash, Ruth, Potter, Mike N, Lancaster, Donna, Rahman, Nazneen

    Published in Journal of medical genetics (01-07-2007)
    “…Familial non-Hodgkin lymphoma (NHL) is rare and in most cases, no underlying cause is identifiable. We report homozygous truncating mutations in the mismatch…”
    Get full text
    Journal Article
  7. 7

    First report of fatal human infections with the cactophilic yeast Sporopachydermia cereana by Anoop, Parameswaran, Riley, Unell, Ethell, Mark E, Treleaven, Jennie, Johnson, Elizabeth M, Morgan, Gareth J, Potter, Mike N

    Published in The Journal of infection (01-04-2011)
    “…Summary Sporopachydermia cereana is a cactophilic yeast, which is not recognised as a human pathogen. We describe two fatal infections with this fungus in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    RELAPSE OF PRIMITIVE MEDIASTINAL LYMPHOMA AS A MYELOID MASS FOLLOWING BEAM AUTOLOGOUS TRANSPLANT AND SUBSEQUENT REFRACTORINESS TO MATCHED UNRELATED UMBILICAL CORD BLOOD ALLOGRAFT by Anoop, Parameswaran, Lancaster, Donna L., Ethell, Mark E., Potter, Mike N., Wotherspoon, Andrew

    Published in Pediatric hematology and oncology (01-03-2009)
    “…Outlining the treatment for an unclassifiable lymphoid malignancy is often difficult. A highly undifferentiated lymphomatous mass that relapsed in spite of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Histologic Features of the Liver Biopsy Predict the Clinical Outcome for Patients with Graft-versus-Host Disease of the Liver by Duarte, Rafael F., Delgado, Julio, Shaw, Bronwen E., Wrench, David J., Ethell, Mark, Patch, David, Dhillon, Amar P., Mackinnon, Stephen, Potter, Mike N., Quaglia, Alberto F.

    “…We reviewed liver histologic results from all allogeneic hematopoietic stem cell transplant recipients from our institution with a confirmed diagnosis of liver…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Duration of Initial Admission and Subsequent Readmission in the First 100 Days Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation by Dungarwalla, Moez, Brennan, Joy, Kulkarni, Samar, Saso, Radovan, Shaw, Bronwen, Jennifer, Treleaven G., Claire, Dearden E., Gareth, Morgan J., Mark, Ethell E., Mike, Potter N.

    Published in Blood (16-11-2007)
    “…Allogeneic stem cell transplantation (allo-SCT) after a reduced intensity conditioning (RIC) protocol is associated with decreased transplant related organ…”
    Get full text
    Journal Article
  14. 14